Hypertension in autosomal dominant polycystic kidney disease.
about
The functions of TRPP2 in the vascular systemSpanish guidelines for the management of autosomal dominant polycystic kidney diseasePolycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathyPolycystic liver disease: an overview of pathogenesis, clinical manifestations and management.ADPKD: Prototype of Cardiorenal Syndrome Type 4Decreased polycystin 2 expression alters calcium-contraction coupling and changes β-adrenergic signaling pathways.A young patient with a family history of hypertension.Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry.Molecular pathways and therapies in autosomal-dominant polycystic kidney diseaseAutosomal dominant polycystic kidney disease in children.Polycystic diseases in visceral organs.Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney diseaseRenal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice.Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.Hypertension and hydronephrosis: rapid resolution of high blood pressure following relief of bilateral ureteric obstruction.Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.Surgical cyst decortication in autosomal dominant polycystic kidney disease.A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease.Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patientsDoes kidney disease cause hypertension?Renal artery occlusion in autosomal dominant polycystic kidney disease.Hypertension in autosomal-dominant polycystic kidney disease (ADPKD).Clinical Trials and a View Toward the Future of ADPKD.Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease.Insights into autosomal dominant polycystic kidney disease by quantitative mass spectrometry-based proteomics.Grayscale ultrasound characteristics of autosomal dominant polycystic kidney disease severity - an adult and pediatric cohort study.Novel treatments of autosomal dominant polycystic kidney diseaseCalcium-phosphate metabolism parameters and erythrocyte Ca(2+) concentration in autosomal dominant polycystic kidney disease patients with normal renal function.Polycystin-2 Plays an Essential Role in Glucose Starvation-Induced Autophagy in Human Embryonic Stem Cell-Derived Cardiomyocytes.Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?Relationship between intracranial aneurysms and the severity of autosomal dominant polycystic kidney disease.Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.New treatment paradigms for ADPKD: moving towards precision medicine.
P2860
Q26771361-A590B46A-3F9F-4A44-A62E-47FE716A1252Q26863397-45129FD6-BFC8-4C9E-B3D8-0E80572569C5Q30539186-169EFC1D-45E2-4C3C-B44A-DB75B0500592Q33648233-EE7A2595-84D7-4C3D-9159-68991349C293Q34475590-0056B816-25F0-4326-B4A1-E3ACD75F2FB0Q34581173-711FEEF4-9561-4308-8DC6-6B04AB3FD436Q34629700-84477044-1F11-43B6-AB24-A59B83BCD55EQ34978995-BA76735E-96F4-483D-8445-14DCAE368DACQ35578646-911913DC-442F-4A30-8203-008D646EA724Q35596375-26991879-D32E-4F28-9247-33A7FEE02CB6Q35660081-B516003F-B087-4C9F-845B-50CE74E3F9C9Q35724647-39680921-6F89-4599-9838-36829F646DD7Q35878445-BA0FC491-8664-4C7D-87F1-2B9CAA0FB317Q36385359-1FE9942A-10D8-4310-9484-CFD3301BA3FAQ36631466-ECFB55B5-0F60-44E5-A14E-B71519B057A4Q36741005-E5EC221C-97B5-45F0-9B24-D6766379A874Q36813725-EB9CE896-16C3-4F8E-B735-26072ACD6049Q37411615-37D87D06-3204-46B0-A3C8-92E4F89828C5Q37606169-9EAC0F0E-73A7-4BFB-80A0-163929A6D9AAQ38076324-EC013D2A-A9FA-445A-B5FA-6D8C4B7B1528Q38211681-088FA3B5-EF86-436B-BA5F-45063DB765CFQ38524722-73E6E2F0-D3C2-45BF-970F-DA1E17AF056EQ38812543-C51E58FF-9495-4D08-B009-1A86130AA2FCQ39252622-B71CE4E1-8028-449D-959E-C3A8BD29B7A1Q39255681-FBBCCE2E-CA11-40EE-8884-D3ABAE350C48Q41051909-48F7E727-69F4-4A8F-8F0B-2C10E4D33332Q42556481-6303EE73-ED6B-4B72-936F-73EF0A736BD8Q42879307-1B53ECFC-CEFC-4601-99CF-77CA30514907Q47261814-B9D88C9E-2250-46F2-8F4C-163935DEF38CQ47344872-D2710399-E8BB-4D6E-A7CA-455F1F44F7D4Q47647205-B141FAC8-64F2-483B-9A67-EAFAC0CA670CQ47742358-CCF76B5C-EE1D-4478-B32A-AA8552CEFFF4Q49494721-D7769D1B-43C2-42EC-8A82-41C9C6ABA20C
P2860
Hypertension in autosomal dominant polycystic kidney disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hypertension in autosomal dominant polycystic kidney disease.
@ast
Hypertension in autosomal dominant polycystic kidney disease.
@en
type
label
Hypertension in autosomal dominant polycystic kidney disease.
@ast
Hypertension in autosomal dominant polycystic kidney disease.
@en
prefLabel
Hypertension in autosomal dominant polycystic kidney disease.
@ast
Hypertension in autosomal dominant polycystic kidney disease.
@en
P2093
P2860
P1476
Hypertension in autosomal dominant polycystic kidney disease.
@en
P2093
Arlene B Chapman
Frederic Rahbari-Oskoui
Konrad Stepniakowski
P2860
P304
P356
10.1053/J.ACKD.2010.01.001
P577
2010-03-01T00:00:00Z